The Tobacco Control Research Branch (TCRB) leads and collaborates on research and disseminates evidence-based findings to prevent, treat, and control tobacco use in order to create a world free of tobacco use and related cancer and suffering. TCRB is within the National Cancer Institute’s (NCI) Behavioral Research Program (BRP), in the Division of Cancer Control and Population Sciences (DCCPS).
- Advertising and marketing of tobacco products
- Epidemiology and surveillance of tobacco knowledge, attitudes, and behavior
- Etiology, predictors, correlates, and determinants of tobacco use, nicotine dependence, and cessation
- Global tobacco control, especially in low- and middle-income countries
- Media and policy to reduce tobacco use
- Other tobacco products, e.g., smokeless tobacco, cigars, roll-your-own, hookah, bidis, etc.
- Potential Reduced-Exposure Tobacco Products (PREPs)
- Secondhand smoke
- Tobacco cessation interventions at the individual, system, and population levels
- Tobacco control interventions for underserved and at-risk populations
- Tobacco industry documents
- Tobacco prevention interventions at the individual, system, and population levels
- Tobacco product analysis, e.g., design and composition, constituents and additives, processing, manufacturing
- Tobacco use and cessation in cancer screening, diagnosis, treatment, and survivorship
- Tobacco-related disparities
News and Highlights
- Register now for the Tobacco Longitudinal Mortality Study (TLMS) webinar on March 16, 2023
- Now accepting Letters of Interest for a Scientific Position in Tobacco Control Research
- JCO Oncology Practice article – Treating Smoking in Cancer Patients: An Essential Component of Cancer Care-The New National Cancer Institute Tobacco Control Monograph
- FDA Proposes Rule Prohibiting Menthol Cigarettes – Cancer Currents Blog
Grant Portfolio and Funding Opportunities
Johannes Thrul, Ph.D.
I am excited about the potential of mobile health methods to test mechanisms of action and "active ingredients" of behavioral interventions.”Johannes Thrul, Ph.D.
Ana-Paula Cupertino, Ph.D.
I have been fascinated with the opportunity to translate my smoking cessation mobile research interventions into business models to increase access to Latino smokers in the U.S., Mexico and Brazil.”Ana-Paula Cupertino, Ph.D.
Rajani S. Sadasivam, Ph.D.
I tested computer-tailored health communication (CTHC) techniques I learned in a 2007 workshop in a nationwide randomized control trial with 900 smokers. The system worked, and I realized the power of CTHC to help patients. During this time, companies like Amazon were using big data methods to adapt to users' continuous feedback (their collective intelligence) to tailor content. I realized that these methods could make CTHC even more powerful, and I have pursued this line of research since then.”Rajani S. Sadasivam, Ph.D.
Read peer-reviewed manuscripts, funding analyses, and reports on behavioral research issues in cancer prevention and control.
Learn about TCRB’s organizational structure and team members. See selected funding opportunities.
Information & Resources
Learn about TCRB’s latest initiatives and tools for researchers, patients, and more.
Meet Our Staff
Our team of accomplished scientists and research associates, fellows, and administrators is dedicated to advancing behavioral science research in cancer prevention and control.TCRB Staff